Previous close | 568.00 |
Open | 580.48 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 568.00 - 586.33 |
52-week range | 336.03 - 661.60 |
Volume | |
Avg. volume | 946 |
Market cap | 42.284B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 60.63 |
EPS (TTM) | 9.67 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 4.57 (0.78%) |
Ex-dividend date | 13 May 2024 |
1y target est | N/A |
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...
Key Insights The considerable ownership by individual investors in Lonza Group indicates that they collectively have a...